Skip to main content
Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
14.00
+0.43 (3.17%)
At close: Mar 9, 2026, 4:00 PM EDT
14.00
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT

Theravance Biopharma Revenue

Theravance Biopharma had revenue of $19.99M in the quarter ending September 30, 2025, with 18.51% growth. This brings the company's revenue in the last twelve months to $80.33M, up 27.12% year-over-year. In the year 2024, Theravance Biopharma had annual revenue of $64.38M with 12.12% growth.

Revenue (ttm)
$80.33M
Revenue Growth
+27.12%
P/S Ratio
8.64
Revenue / Employee
$828,113
Employees
97
Market Cap
709.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202464.38M6.96M12.12%
Dec 31, 202357.42M6.08M11.84%
Dec 31, 202251.35M-3.97M-7.17%
Dec 31, 202155.31M-16.55M-23.03%
Dec 31, 202071.86M-1.56M-2.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MiMedx Group 418.63M
Gyre Therapeutics 107.27M
Lexicon Pharmaceuticals 49.80M
Prime Medicine 4.63M
ProKidney 744.00K
Revenue Rankings

TBPH News

More News